IHC determined that C14orf166 was upregulated in both T1 and T2 bladder cancer tissues compared to the normal bladder tissues, C14orf166 expression in the T2 samples was higher than that in the T1 samples (Fig. 2b). The gene discussed is RTRAF; the disease is urinary bladder carcinoma.